BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16009836)

  • 1. Quantitative phenotyping of chromatic dysfunction in best macular dystrophy.
    Campos SH; Forjaz V; Kozak LR; Silva E; Castelo-Branco M
    Arch Ophthalmol; 2005 Jul; 123(7):944-9. PubMed ID: 16009836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
    Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
    Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatic-contrast threshold impairment in diabetes.
    Tregear SJ; Knowles PJ; Ripley LG; Casswell AG
    Eye (Lond); 1997; 11 ( Pt 4)():537-46. PubMed ID: 9425421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal function in best macular dystrophy: relationship between electrophysiological, psychophysical, and structural measures of damage.
    Maia-Lopes S; Silva ED; Reis A; Silva MF; Mateus C; Castelo-Branco M
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5553-60. PubMed ID: 18775865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of widespread retinal dysfunction in patients with stargardt disease and morphologically unaffected carrier relatives.
    Maia-Lopes S; Silva ED; Silva MF; Reis A; Faria P; Castelo-Branco M
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1191-9. PubMed ID: 18326749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity staging by early features of age-related maculopathy exhibits weak relationships with functional deficits on SWS grating acuity.
    Beirne RO; Hogg RE; Stevenson MR; Zlatkova MB; Chakravarthy U; Anderson RS
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4624-31. PubMed ID: 17003460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colour discrimination ellipses in choroideremia.
    Seitz IP; Jolly JK; Dominik Fischer M; Simunovic MP
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):665-673. PubMed ID: 29404760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colour contrast sensitivity in patients with age-related Bruch's membrane changes.
    Holz FG; Gross-Jendroska M; Eckstein A; Hogg CR; Arden GB; Bird AC
    Ger J Ophthalmol; 1995 Nov; 4(6):336-41. PubMed ID: 8751098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid quantification of color vision: the cone contrast test.
    Rabin J; Gooch J; Ivan D
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):816-20. PubMed ID: 21051721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of chromatic sensitivity in AMD and diabetes: a comparative study.
    O'Neill-Biba M; Sivaprasad S; Rodriguez-Carmona M; Wolf JE; Barbur JL
    Ophthalmic Physiol Opt; 2010 Sep; 30(5):705-16. PubMed ID: 20883358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals.
    Michaelides M; Johnson S; Simunovic MP; Bradshaw K; Holder G; Mollon JD; Moore AT; Hunt DM
    Eye (Lond); 2005 Jan; 19(1):2-10. PubMed ID: 15094734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous comparison of relative damage to chromatic pathways in ocular hypertension and glaucoma: correlation with clinical measures.
    Castelo-Branco M; Faria P; Forjaz V; Kozak LR; Azevedo H
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):499-505. PubMed ID: 14744891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orientational contrast sensitivity and chromatic contrast thresholds in multiple sclerosis.
    Jackson TL; Ong GL; Ripley LG
    Am J Ophthalmol; 2004 Feb; 137(2):283-6. PubMed ID: 14962418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Color vision in the tritan axis is predominantly affected at high altitude.
    Tekavcic-Pompe M; Tekavcic I
    High Alt Med Biol; 2008; 9(1):38-42. PubMed ID: 18331219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Color matches in diseased eyes with good acuity: detection of deficits in cone optical density and in chromatic discrimination.
    Swanson WH; Fish GE
    J Opt Soc Am A Opt Image Sci Vis; 1995 Oct; 12(10):2230-6. PubMed ID: 7500203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male prevalence of acquired color vision defects in asymptomatic carriers of Leber's hereditary optic neuropathy.
    Ventura DF; Gualtieri M; Oliveira AG; Costa MF; Quiros P; Sadun F; de Negri AM; Salomão SR; Berezovsky A; Sherman J; Sadun AA; Carelli V
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2362-70. PubMed ID: 17460303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation between visual acuity and color vision as an indicator of the cause of visual loss.
    Almog Y; Nemet A
    Am J Ophthalmol; 2010 Jun; 149(6):1000-4. PubMed ID: 20378093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cone-specific measures of human color vision.
    Rabin J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2771-4. PubMed ID: 8977494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual colour detection abilities in age-related macular degeneration.
    Shima N; Markowitz SN; Reyes SV
    Can J Ophthalmol; 2013 Aug; 48(4):274-8. PubMed ID: 23931466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.